Skip to Main Content

Ibotta, Inc. (NYSE: IBTA) Securities Fraud Investigation

On or around April 13, 2024, Ibotta conducted its initial public offering of 6.6 million shares priced at $88.00 per share.  Then, on August 13, 2024, Ibotta issued a press release reporting its financial results for the second quarter of 2024.  In the results, Ibotta reported, among other items, a net loss of $34.0 million, attributable to operating expenses that more than doubled year-over-year. Ibotta also provided a third quarter revenue forecast in the range of $91 million to $96 million, below consensus estimates.  On this news, Ibotta's stock price fell sharply on August 14, 2024, from a close of $58.19 per share on August 13, 2024, to close at $42.66 per share on August 14, 2024.  

If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP:  Jonathan Naji, Esq. (484) 270-1453 or via e-mail at info@ktmc.com.  

Complete this form with your transactions in Ibotta, Inc.
 securities pursuant and/or traceable to IPO on or about April 18, 2024.

Click Here to Print PDF of this Form

SUBMIT YOUR INFORMATION
* Denotes required field
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Ibotta, Inc. prior to the Class Period?
Are you a current or former employee of Ibotta, Inc. ?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email